[Donald] Trump’s allies have mocked the persistent focus on the president’s health, saying that many questions about his medication, appearance and aging are irrelevant to his performance. But Robert Klitzman, a psychiatrist who leads Columbia University’s master’s program in bioethics, said the White House’s lack of transparency about Trump’s use of a hair-loss drug may reflect its unwillingness to be honest about the nearly 80-year-old president’s health. “It raises significant questions of what else is possibly not being revealed,” Klitzman said. He also noted that use of finasteride has been linked with an increased risk of depression, which could affect a president’s performance, adding that it was “crucial” for Trump to be open about his health and medications.
—The Hair-loss Drug Trump Took for Years Is Now Absent from his Medical Records: The Washington Post, June 4, 2026